Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study
Open Access
- 30 January 2009
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 13 (1) , R10
- https://doi.org/10.1186/cc7703
Abstract
Introduction: Pumpless interventional lung assist (iLA) is used in patients with acute respiratory distress syndrome (ARDS) aimed at improving extracorporeal gas exchange with a membrane integrated in a passive arteriovenous shunt. In previous studies, feasibility and safety of the iLA system was demonstrated, but no survival benefit was observed. In the present pilot study we tested the hypothesis that timely initiation of iLA using clear algorithms and an improved cannulation technique will positively influence complication rates and management of lung protective ventilation. Methods: iLA was implemented in 51 patients from multiple aetiologies meeting ARDS-criteria (American-European Consensus) for more than 12 hours. Initiation of iLA followed an algorithm for screening, careful evaluation and insertion technique. Patients with cardiac insufficiency or severe peripheral vascular disease were not considered suitable for iLA. Arterial and venous cannulae were inserted using a new strategy (ultrasound evaluation of vessels by an experienced team, using cannulae of reduced diameter). The incidence of complications and the effects on tidal volumes and inspiratory plateau pressures were primary outcome parameters, while oxygenation improvement and carbon dioxide removal capabilities were secondary study parameters. Results: Initiation of iLA resulted in a marked removal in arterial carbon dioxide allowing a rapid reduction in tidal volume (≤ 6 ml/kg) and inspiratory plateau pressure. Adverse events occurred in 6 patients (11.9%). The hospital mortality rate was 49%. Conclusions: The use of an indication algorithm for iLA in early ARDS, combined with a refined application technique was associated with efficient carbon dioxide removal and a reduced incidence of adverse events. iLA could serve as an extracorporeal assist to support mechanical ventilation by enabling low tidal volume and a reduced inspiratory plateau pressure.Keywords
This publication has 23 references indexed in Scilit:
- First experiences with a new miniaturised life support system for mobile percutaneous cardiopulmonary bypassResuscitation, 2008
- Evidence-based Therapy of Severe Acute Respiratory Distress Syndrome: An Algorithm-guided ApproachJournal of International Medical Research, 2008
- An Early PEEP/FiO2 Trial Identifies Different Degrees of Lung Injury in Patients with Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2007
- A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia*Critical Care Medicine, 2006
- Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assistBritish Journal of Anaesthesia, 2006
- Tidal Volume Reduction in Patients with Acute Lung Injury When Plateau Pressures Are Not HighAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2004
- Pumpless extracorporeal lung assist – experience with the first 20 casesEuropean Journal of Cardio-Thoracic Surgery, 2000
- Treatment of Acute Respiratory Failure by Extracorporeal Carbon Dioxide Elimination Performed with a Surface Heparinized Artificial LungAnesthesiology, 1987
- Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective studyJAMA, 1979